Karl Nägler
Direktor/Vorstandsmitglied bei Confo Therapeutics NV
Ursprung des Netzwerks ersten Grades von Karl Nägler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Gimv (Private Equity)
 Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.
21
| Operating Division | Investment Managers | 21 |
Gimv Germany
17
| Operating Division | Investment Managers | 17 |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.
17
| Private Company | Investment Managers | 17 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Ventech SA
 Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US.
6
| Subsidiary | Investment Managers | 6 |
Atlas Venture GmbH
 Atlas Venture GmbH Investment ManagersFinance Atlas Venture GmbH was the Munich office of the independent and partner-owned venture capital investment group Atlas Venture Inc., headquartered in Boston with additional offices in London and Paris, plus an administrative office in Amsterdam. The group originated in 1980 and focuses on high-technology financing, aiming for a transatlantic operations model. The Munich office was established in the late 1990s. The group manages a range of venture capital funds. Atlas Venture GmbH was liquidated in 2009.
3
| Extinct | Investment Managers | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Karl Nägler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
KBC Asset Management NV
 KBC Asset Management NV Investment ManagersFinance KBC Asset Management NV (KBC AM) is the wholly-owned asset management subsidiary of KBC Bank NV, itself a subsidiary of KBC Group SA/NV (XB: KBC; ADR: KBCSY) in Belgium. The firm was founded in 2000 and is previously a division of KBC Bank. Headquartered in Brussels, KBC AM provides asset management services to private individuals, corporate clients and institutions. They also manage a range of mutual funds across various asset classes, markets and strategies. | Investment Managers | Head-Equity Investments Analyst-Equity | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GIMV NV | Investment Managers | Chief Executive Officer Comptroller/Controller/Auditor Director of Finance/CFO | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
KBC Securities NV
 KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Cegeka NV
 Cegeka NV Information Technology ServicesTechnology Services Cegeka NV engages in the provision of information and communication technology solutions. It offers cloud, software, outsourcing, business process, digital experience, data and automation, and training services. The firm servers the agriculture, food, energy, utilities, manufacturing, retail, leisure, aviation, mobility, healthcare, and telecom industries. The company was founded by André Knaepen in 1992 and is headquartered in Hasselt, Belgium. | Information Technology Services | Director/Board Member Director/Board Member | |
| Technische Universität München | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
EnOcean GmbH
 EnOcean GmbH Electronic Production EquipmentElectronic Technology EnOcean GmbH develops and provides patented self-powered wireless technology. It manufactures and markets maintenance-free wireless sensor solutions for use in buildings and industrial installations. The firm's solutions are based on miniaturized energy converters, ultra-low-power electronic circuitry, and reliable wireless. Its products include accessories, software and firmware. The company was founded by Andreas Schneider and Frank Schmidt in 2001 and is headquartered in Oberhaching, Germany. | Electronic Production Equipment | Director/Board Member Director/Board Member | |
PamGene BV
 PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Director/Board Member Chairman | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Polpharma Biologics Utrecht BV
 Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ghent University | College/University | Undergraduate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| École Centrale Paris | College/University | Undergraduate Degree Graduate Degree | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member | |
| Vlerick Leuven Gent Management School | College/University | Graduate Degree Masters Business Admin | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst Private Equity Investor | |
b2venture AG
 b2venture AG Investment ManagersFinance btov Partners AG (btov) is a venture capital firm founded in 2000 by St. Gallen University students as an online job platform BrainsToVentures, with backing from Swiss business angels. The firm is headquartered in St. Gallen, Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
| IMPLANET SA | Medical Specialties | Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Founder Private Equity Investor | |
Luciad NV
 Luciad NV Packaged SoftwareTechnology Services Luciad NV designs and develops visualization and geospatial software products. The firm’s solutions include browser, server, AIXM 5 viewer, desktop, mobile, air traffic control and lucy test drive. The company was founded by Lode Missiaen and Thierry Salvant in 1999 and is headquartered in Leuven, Belgium. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member | |
Cegeka Business Solutions
 Cegeka Business Solutions Information Technology ServicesTechnology Services Cegeka Business Solutions engages in the provision of enterprise resource planning software solutions. It provides Microsoft Dynamics, Microsoft Stack, and Axapta and Navision. It offers solutions to food and process industries, wholesale and distribution, and construction and installation companies. The company is headquartered in Gent, Belgium. | Information Technology Services | Director/Board Member Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Wellington Partners Advisory AG | Corporate Officer/Principal Director of Finance/CFO | ||
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Mnemo Therapeutics SAS
 Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Founder Chairman | |
Adviesbeheer Gimv Health & Care 2016 NV
 Adviesbeheer Gimv Health & Care 2016 NV Financial ConglomeratesFinance Adviesbeheer Gimv Health & Care 2016 NV is an investment holding Belgian company that provides management, investment, real estate, and public relation services. The company was founded in 2016 and is based in Antwerp, Belgium. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Cegeka Groep NV
 Cegeka Groep NV Information Technology ServicesTechnology Services Cegeka Groep NV provides IT solutions. The private company is based in Hasselt, Belgium. The Belgian company was founded in 1992 by André Knaepen. The CEO is Stijn Bijnens. | Information Technology Services | Director/Board Member Director/Board Member | |
Europlasma NV
 Europlasma NV Electrical ProductsProducer Manufacturing Europlasma NV engages in the design and manufacture of vacuum plasma treatment equipment. It offers process development and contract research and development, equipment manufacturing, subcontracting treatment, maintenance contracts, and technical services. The company was founded in 1993 and is headquartered in Oudenaarde, Belgium. | Electrical Products | Director/Board Member Chairman |
Statistik
International
| Belgien | 19 |
| Frankreich | 14 |
| Deutschland | 6 |
| Vereinigte Staaten | 5 |
| Niederlande | 5 |
Sektoral
| Health Technology | 20 |
| Finance | 11 |
| Consumer Services | 9 |
| Technology Services | 5 |
| Commercial Services | 5 |
Operativ
| Director/Board Member | 439 |
| Private Equity Investor | 89 |
| Chairman | 57 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 46 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Koen Dejonckheere | 46 |
| Raphaël Wisniewski | 45 |
| Eric Archambeau | 43 |
| Regina Hodits | 34 |
| Bo Jesper Hansen | 34 |
| Dieter Weinand | 32 |
| Rémi Droller | 29 |
| Patrick van Beneden | 28 |
| Florent Gros | 28 |
| Stuart Essig | 21 |
| Edward van Wezel | 20 |
| Thibaut Roulon | 18 |
| Frank Böhnke | 15 |
| Alexandra Tolia | 15 |
| Erich Schlick | 15 |
- Börse
- Insiders
- Karl Nägler
- Unternehmensverbindungen